Clinical Trial Update: Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

View source ↗

Summary

A real-world study evaluating ABBV-951 subcutaneous infusion to assess change in disease activity in adults with Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABBV-951

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Status: RECRUITING